CAPSONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.902
EU - Europa 9.697
AS - Asia 6.700
SA - Sud America 875
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 48
OC - Oceania 9
Totale 31.299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.750
IT - Italia 3.029
SG - Singapore 2.109
CN - Cina 1.929
SE - Svezia 1.618
IE - Irlanda 1.246
KR - Corea 1.089
RU - Federazione Russa 1.024
DE - Germania 861
BR - Brasile 776
TR - Turchia 705
UA - Ucraina 602
GB - Regno Unito 436
HK - Hong Kong 361
FI - Finlandia 326
CH - Svizzera 129
VN - Vietnam 107
CA - Canada 99
AT - Austria 89
IL - Israele 62
JP - Giappone 59
FR - Francia 57
IN - India 57
BE - Belgio 53
PL - Polonia 49
EU - Europa 46
NL - Olanda 43
AR - Argentina 36
MX - Messico 36
BD - Bangladesh 34
ES - Italia 32
ID - Indonesia 29
ZA - Sudafrica 29
AL - Albania 25
AE - Emirati Arabi Uniti 20
IQ - Iraq 19
VE - Venezuela 18
PK - Pakistan 17
UZ - Uzbekistan 16
EC - Ecuador 14
JO - Giordania 12
LT - Lituania 12
TW - Taiwan 10
CZ - Repubblica Ceca 9
DK - Danimarca 9
MA - Marocco 9
CO - Colombia 8
RS - Serbia 8
BN - Brunei Darussalam 7
SA - Arabia Saudita 7
AU - Australia 6
CL - Cile 6
HU - Ungheria 6
KE - Kenya 6
LU - Lussemburgo 5
TH - Thailandia 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
EG - Egitto 4
IR - Iran 4
JM - Giamaica 4
KZ - Kazakistan 4
PE - Perù 4
PS - Palestinian Territory 4
PY - Paraguay 4
RO - Romania 4
BO - Bolivia 3
DZ - Algeria 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
GM - Gambi 2
GR - Grecia 2
HN - Honduras 2
IM - Isola di Man 2
KG - Kirghizistan 2
LI - Liechtenstein 2
MD - Moldavia 2
MN - Mongolia 2
MT - Malta 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BF - Burkina Faso 1
BW - Botswana 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 31.274
Salva come PNG Salva come JPEG
Città #
Pisa 2.187
Dallas 1.696
Chandler 1.357
Jacksonville 1.292
Dublin 1.243
Ashburn 1.191
Seoul 1.083
Singapore 980
Boardman 851
Izmir 529
Wilmington 525
Hefei 411
Ann Arbor 386
Hong Kong 355
Boston 308
Moscow 292
The Dalles 287
Millbury 263
Beijing 233
New York 229
Düsseldorf 226
Munich 211
Kent 192
Mestre 188
San Mateo 180
Los Angeles 158
Istanbul 150
Ogden 120
Bremen 118
Seattle 118
Bern 107
Princeton 106
Washington 94
Helsinki 93
Lawrence 90
Woodbridge 85
Vienna 78
São Paulo 71
Milan 69
San Paolo di Civitate 67
Guangzhou 66
Saint Petersburg 63
Chicago 62
Shanghai 60
Santa Clara 56
Columbus 54
Dearborn 53
Turku 52
Holon 51
North Bergen 51
Tokyo 50
Brussels 48
Council Bluffs 44
Rome 43
Warsaw 42
Dong Ket 39
Toronto 39
Wuhan 39
Buffalo 38
Scuola 38
London 34
Frankfurt am Main 33
Montreal 33
Denver 32
Brooklyn 31
Atlanta 28
San Giuliano Terme 28
Houston 27
Stockholm 27
Fairfield 26
Orem 26
Belo Horizonte 24
Jakarta 24
Norwalk 23
Chennai 22
Ho Chi Minh City 22
Las Vegas 22
Nanjing 22
Rio de Janeiro 22
Johannesburg 20
San Francisco 20
Amsterdam 18
Brasília 18
Hanoi 18
Florence 17
Shenzhen 17
Bientina 16
Mexico City 16
Poplar 16
Edinburgh 15
Jiaxing 15
Phoenix 15
Salt Lake City 15
Andover 14
Ankara 14
Kunming 14
Paris 13
San Diego 13
Tashkent 13
Wuxi 13
Totale 20.043
Salva come PNG Salva come JPEG
Nome #
Initial events leading to ß amyloid expression in anti-NGF transgenic mice. 2.613
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 331
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 302
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 280
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 276
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 268
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 253
Graphene promotes axon elongation through local stall of Nerve Growth Factor signaling endosomes 249
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 245
NGF steers microglia toward a neuroprotective phenotype 241
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 240
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 240
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 235
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 232
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 231
A new generation of NGF-based therapy for Alzheimer’s disease 229
A small molecule targeting the multifactorial nature of Alzheimer's disease 227
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. 220
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 218
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 217
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 216
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 215
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 211
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 205
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 205
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 203
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 202
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 201
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 201
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 199
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 194
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 192
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 191
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 190
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 190
Abeta-Dependent Inhibition of LTP in Different Intra-Cortical Circuits of the Visual Cortex: The role of RAGE 189
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 187
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 185
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 182
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 182
A microglial function for the nerve growth factor : predictions of the unpredictable 181
Nerve Growth Factor regulates astrocyte physiology in vivo 181
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 178
Human TrkAR649W mutation impairs nociception, sweating and cognitive abilities : a mouse model of HSAN IV 177
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 177
Amelioration of the neurodegenerative phenotype in AD11 anti-NGF mice 176
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology 176
Targeting the cation-chloride co-transporter NKCC1 to re-establish GABAergic inhibition and an appropriate excitatory/inhibitory balance in selective neuronal circuits: a novel approach for the treatment of Alzheimer's disease 172
The role of Nerve Growth Factor in development and in ALzheimer's disease 172
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 171
Involvement of NGF in early stages of chick embryo development 168
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 167
ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic Mice 166
IN VITRO RECEPTOR BINDING PROPERTIES OF A "PAINLESS" NGF MUTEIN, LINKED TO HEREDITARY SENSORY AUTONOMIC NEUROPATHY TYPE V 164
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 164
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection 163
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 163
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 162
Intranasal delivery of therapeutic proteins for neurological diseases 162
Development of a non-invasive NGF-based therapy for Alzheimer's disease. Current Alzheimer Research 6: 158 159
Role of NGF in modulating adult neurogenesis in an Alzheimer's disease mouse model 157
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 155
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 155
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 153
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 153
Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome 152
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 151
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. 151
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 150
Morphological basis for pineal secretion in domestic Ungulata 150
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 148
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 148
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 148
Memoquin: a new compound to attack Alzheimer disease on multiple fronts 148
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 147
Cholinesterase inhibitors with nicotinic mode of action: Neuroprotection in anti-NGF mice 147
Inflammatory responses in anti-Nerve Growth Factor transgenic mice 147
Nerve Growth Factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 145
Rat visual cortical neurones express TrkA NGF receptor 145
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 143
Autoradiographic quantification of endothelin ET(A)receptors in peripheral and brain arteries of the rat 143
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 142
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J Alzheimers Dis 16: 371 142
Nerve growth factor regulates axial rotation during early stages of chick embryo development 141
Transgenic mouse models of neurotrophin function and effects on amyloid plaques and neurofibrillary pathology 141
Long-term memantine treatment prevents behaviour deficits in a mouse model of sporadic Alzheimer's disease 141
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 139
Early involvement of inflammation and immune response mRNAs in the brain of anti-Nerve Growth Factor AD11 mice, as revealed by gene expression profiling 139
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 139
Environmental enrichment rescues visual memory deficits in a mouse model of Alzheimer disease after the onset of neurodegeneration 138
PHENOTYPIC KNOCKOUT OF NERVE GROWTH FACTOR IN ADULT TRANSGENIC MICE REVEALS SEVERE DEFICITS IN BASAL FOREBRAIN CHOLINERGIC NEURONS, CELL DEATH IN THE SPLEEN, AND SKELETAL MUSCLE DYSTROPHY 138
The richness of the environment bidirectionally affects the progression of the disease in a mous emodel of Alzheimer's disease, the AD11 mice 138
Postnatal development of astrocytes in mouse visual cortex: role of the visual experience 138
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 138
Expression of the melatonin receptors in Xenopus laevis 138
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 138
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 137
Effects of combination treatment of galantamine and memantine on AD11 anti-NGF mice 136
Rage deficiency rescues Aß-mediated inhibitory effects of different forms of long-term potentiation in mouse neocortex 135
The effects of knocking out of p75NTR on the neurodegenerative phenotype in AD11 anti-NGF mice 135
Totale 20.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.870
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.504 0 0 0 0 0 216 75 193 209 409 127 275
2021/20221.454 141 13 11 78 97 19 31 125 91 75 70 703
2022/20236.112 408 369 255 419 374 592 4 1.555 1.841 32 121 142
2023/20241.901 268 46 212 47 132 384 70 106 208 72 10 346
2024/20258.696 1.664 292 267 735 899 178 584 335 1.253 429 975 1.085
2025/20266.994 928 1.433 2.154 1.404 999 76 0 0 0 0 0 0
Totale 31.576